This is an optimized Investor Page for viewing on mobile devices, to view our entire Investor Relations site click here.
Aug 26, 2008
FDA Issues Complete Response Letter for Paliperidone Palmitate for the Treatment of Schizophrenia
> Read More
Aug 21, 2008
FDA Requires Additional Information on Doribax for Treatment of Hospital-Acquired Pneumonia
> Read More
Aug 11, 2008
Ethicon Endo-Surgery To Acquire SurgRx
> Read More
Aug 8, 2008
FDA EXTENDS REVIEW TIMELINE FOR USTEKINUMAB BIOLOGIC LICENSE APPLICATION THREE MONTHS
> Read More
Aug 5, 2008
Ninety-Six Week Data On Tibotec Investigational NNRTI, TMC278, Presented At AIDS 2008
> Read More
Oct 14, 2008 at 8:30 AM ET
Johnson & Johnson Third Quarter 2008 Earnings Meeting
Jan 20, 2009 at 8:30 AM ET
Johnson & Johnson Fourth Quarter and Year End 2008 Earnings Meeting
© 1992-2008 JNJ Systems, Inc. All rights reserved.